Chaparral Labs
back to search

protein

Histone-lysine N-methyltransferase 2A

aka Lysine N-methyltransferase 2A

KMT2A
protein:Q03164sfari:Ssfari:syndromicdisease:asd

Gene

KMT2A

Organism

Homo sapiens(9606)

Length

3969 aa

Mass

431,764 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

KMT2A (Histone-lysine N-methyltransferase 2A) is a chromatin-modifying enzyme that catalyzes methylation of lysine-4 on histone H3 (H3K4me) as the catalytic subunit of the MLL1/MLL complex (UniProt: Q03164). The protein also facilitates histone H4 acetylation and works with other complex components to establish active chromatin states. KMT2A requires cofactors for full methyltransferase activity and binds unmethylated CpG elements to maintain their nonmethylated state.

KMT2A plays essential roles in early development, hematopoiesis, and circadian gene regulation by establishing permissive chromatin for transcription activation, particularly of genes like HOXA9. Mutations in KMT2A cause Wiedemann-Steiner syndrome (WDSTS), characterized by intellectual disability, distinctive facial features including long eyelashes and thick eyebrows, hypertrichosis cubiti, and short stature (UniProt: Q03164).

KMT2A is classified as a syndromic autism-risk gene in SFARI (SFARI Cat S), indicating association with autism in the context of broader developmental syndromes. This reflects the protein's critical role in neurodevelopmental processes through epigenetic regulation of transcription during early brain development.

Generated from the curated entity record below. May contain errors — verify against source links.

Genetic Evidence · ASD

Syndromic

Source: SFARI Gene database · gene.sfari.org

Related Publications

Browse all →

Function

Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:24235145, PubMed:26886794). Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:12453419, PubMed:15960975, PubMed:19187761, PubMed:19556245, PubMed:20677832, PubMed:21220120, PubMed:25561738, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' (PubMed:19187761). Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20010842, PubMed:20677832). Promotes PPP1R15A-induced apoptosis (PubMed:10490642). Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate (PubMed:24235145)

Disease associations

  • Wiedemann-Steiner syndromeWDSTS

    A syndrome characterized by hairy elbows (hypertrichosis cubiti), intellectual disability, a distinctive facial appearance, and short stature. Facial characteristics include long eyelashes, thick or arched eyebrows with a lateral flare, and downslanting and vertically narrow palpebral fissures.

Sources

Last updated 5/6/2026, 5:24:31 AM